Small cell carcinoma of the ovary hypercalcemic type (SCCOHT): A review and novel case with dual germline SMARCA4 and BRCA2 mutations.
pubmed.ncbi.nlm.nih.gov shows its articles on its own site.
Read the article on pubmed.ncbi.nlm.nih.gov ↗Article · Nov 2026 · 1 min read
In brief
In brief
This case report describes a rare presentation of small cell carcinoma of the ovary hypercalcemic type (SCCOHT) in a patient with dual germline mutations in both SMARCA4 and BRCA2. The authors detail the clinical presentation, pathology findings, and multimodal treatment approach including systemic chemotherapy and hyperthermic intraperitoneal chemotherapy for this aggressive malignancy.
Written by the GCMD Library team from the article.
Statements in this article
Small cell carcinoma of the ovary hypercalcemic type (SCCOHT) is a rare and aggressive disease.
SCCOHT is classically linked to mutations in SMARCA4.
A case of SCCOHT has been identified in a patient with both SMARCA4 and BRCA2 germline mutations.
Treatment approaches for SCCOHT include adjuvant systemic chemotherapy, interval hyperthermic intraperitoneal chemotherapy, and high-dose chemotherapy.